For citations:
Komarov T.N., Bagaeva N.S., Karnakova K.K., Zaslavskaya K.Ya., Bely P.A., Shohin I.E. Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia). Drug development & registration. 2024;13(1):216-223. (In Russ.) https://doi.org/10.33380/2305-2066-2024-13-1-1644
Email this article 